TWP
NVO

Tyche Wealth Partners’s Novo Nordisk NVO Stock Holding History

Tyche Wealth Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,460
Closed -$227K – 358
2025
Q4 		$227K Buy
+4,460
New +$228K 0.04% 302
2024
Q4 		– Sell
-3,365
Closed -$401K – 316
2024
Q3 		$401K Sell
3,365
-3,021
-47% -$403K 0.09% 160
2024
Q2 		$912K Buy
6,386
+607
+11% +$80.4K 0.22% 76
2024
Q1 		$742K Buy
+5,779
New +$688K 0.18% 96

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Tyche Wealth Partners's NVO Position: Q1 2026 in Review

Tyche Wealth Partners sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,460 shares — an estimated $227K sold.

Tyche Wealth Partners first reported a position in NVO in Q1 2024 and held it in 4 quarters. The position peaked at $912K in Q2 2024. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Tyche Wealth Partners reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Tyche Wealth Partners sold 4,460 Novo Nordisk shares in Q1 2026, an estimated $227K.
  • Tyche Wealth Partners first reported a position in Novo Nordisk in Q1 2024 and held it in 4 quarters.
  • Tyche Wealth Partners's Novo Nordisk position peaked at $912K in Q2 2024.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Tyche Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.